Feline injection site sarcomas

Veterinary Clinics of North America - Small Animal Practice

Volumn 33, Issue 3, 2003, Pages 553-571

  Hauck, Marlene ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ADJUVANT; ALUMINUM; AMMONIUM SULFATE; BACTERIAL VACCINE; BASIC FIBROBLAST GROWTH FACTOR; BLOOD CLOTTING FACTOR 13A; CARBOPLATIN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOKERATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; EPITHELIAL MEMBRANE ANTIGEN; FELINE LEUKEMIA VIRUS VACCINE; IMATINIB; INACTIVATED VIRUS VACCINE; INTERLEUKIN 12; LIVE VACCINE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; PROTEIN S 100; RABIES VACCINE; UNINDEXED DRUG; VINCRISTINE; VINCRISTINE SULFATE; VIRUS ANTIGEN; VIRUS VACCINE; VON WILLEBRAND FACTOR;

ANIMAL DISEASE; ANTINEOPLASTIC ACTIVITY; BEAM THERAPY; BRACHYTHERAPY; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CYTOPATHOLOGY; DRUG CARCINOGENICITY; DRUG FORMULATION; DRUG INDUCED CANCER; FIBROSARCOMA; GENE THERAPY; HISTOPATHOLOGY; INJECTION SITE; NONHUMAN; PANNICULITIS; RAT; REVIEW; SUBCUTANEOUS NODULE; TUMOR BIOPSY; VIRUS CARCINOGENESIS;

ANIMALIA; BACTERIA (MICROORGANISMS); FELIDAE; FELINE LEUKEMIA VIRUS;

EID: 0038079760     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(03)00006-8     Document Type: Review

References (69)

1. Hendrick MJ, Dunagan CA. Focal necrotizing granulomatous panniculitis associated with subcutaneous injection of rabies vaccine in cats and dogs: 10 cases (1988-1989). JAVMA 1991;198:304-5.
2. Hendrick MJ, Goldschmidt MH. Do injection site reactions induce fibrosarcomas in cats? JAVMA 1991;199:968.
3. Thornburg LP. Postvaccination sarcomas in cats. JAVMA 1993;203:193-4.
4. Hendrick MJ, Goldschmidt MH, Shofer FS, et al. Postvaccinal sarcomas in the cat: epidemiology and electron probe microanalytical identification of aluminum. Cancer Res 1992;52:5391-4.
5. Slater DN, Underwood JCN, Durrant TE, et al. Aluminum hydroxide granulomas: light and electron microscopic studies and x-ray microanalysis. Br J Dermatol 1982;107:103-8.
6. Kass PH, Barnes WG, Spangler WL, et al. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. JAVMA 1993;203:396-405.
7. Hendrick MJ, Shofer FS, Goldschmidt MH, et al. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats-239 cases (1991-1992). JAVMA 1994;205:1425-9.
8. Esplin DG, McGill LD, Meininger AC, et al. Postvaccination sarcomas in cats. JAVMA 1993;202:1245-7.
9. Coyne MJ, Reeves NCP, Rosen DK. Estimated prevalence of injection-site sarcomas in cats during 1992. JAVMA 1997;210:249-51.
10. Lester S, Clemett T, Burt A. Vaccine site-associated sarcomas in cats-clinical experience and a laboratory review (1982-1993). J Am Anim Hosp Assoc 1996;32:91-5.
11. Hendrick MJ. Historical review and current knowledge of risk factors involved in feline vaccine-associated sarcomas. JAVMA 1998;213:1422-3.
12. Macy DW, Hendrick MJ. The potential role of inflammation in the development of postvaccinal sarcomas in cats. Vet Clin North Am Small Anim Pract 1996;26:103-9.
13. Bergman P, Hendrick MJ, Macy D, et al. Feline sarcoma and vaccination. Vet Forum 1999;March:40-7.
14. Gobar GM, Kass PH. World wide web-based survey of vaccination practices, postvaccinal reactions and vaccine site-associated sarcomas in cats. JAVMA 2002;220:1477-82.
15. Tennant B. Feline injection-site fibrosarcomas: results of a BSAVA survey. J Small Anim Pract 2000;41:181-2.
16. Burton G, Mason KV. Do postvaccinal sarcomas occur in Australian cats? Aust Vet J 1997;75:102-6.
17. Morrison WB, Starr RM. Vaccine-associated feline sarcomas. JAVMA 2001;218:697-702.
18. Starr RM. Vaccine-Associated Feline Sarcoma Task Force: a new model for problem solving in veterinary medicine. JAVMA 1998;213:1428-9.
19. Doddy FD, Glickman LT, Glickman NW, et al. Feline fibrosarcomas at vaccination sites and non-vaccination sites. J Comp Pathol 1996;114:165-74.
20. Hendrick MJ, Brooks JJ. Postvaccinal sarcomas in the cat-histology and immunohistochemistry. Vet Pathol 1994;31:126-9.
21. Madewell BR, Griffey SM, McEntee MC, et al. Feline vaccine associated fibrosarcoma: an ultrastructural study of 20 tumors (1996-1999). Vet Pathol 2001;38:196-202.
22. Dubielzig RR, Everitt J, Shadduck JA, et al. Clinical and morphologic features of post-traumatic ocular sarcomas in cats. Vet Pathol 1990;27:62-5.
23. Dubielzig RR. Ocular sarcoma following trauma in three cats. JAVMA 1984;184:578-81.
24. Macy DW, Chretin J. Local postvaccinal reactions of a recombinant rabbies vaccine. Vet Forum 1999;August:44-9.
25. Schultze AE, Frank LA, Hahn KA. Repeated physical and cytologic characterizations of subcutaneous postvaccinal reactions in cats. Am J Vet Res 1997;58:719-24.
26. Murray J. Vaccine injection-site sarcoma in a ferret. JAVMA 1998;213:955.
27. Carroll EE, Dubielzig RR, Schultz RD. Cats differ from mink and ferrets in their response to commercial vaccines: a histologic comparison of early vaccine reactions. Vet Pathol 2002;39:216-27.
28. Esplin DG, Bigelow M, McGill LD, et al. Fibrosarcoma at the site of a lufenuron injection in a cat. Vet Cancer Soc Newsletter 1999;23:8-9.
29. Macy DW. The potential role and mechanisms of FeLV vaccine-induced neoplasms. Semin Vet Med Surg 1995;10:234-7.
30. Martins-Green M, Boudreau N, Bissell MJ. Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus. Cancer Res 1994;54:4334-41.
31. Dambach D, Carlson J, Riddle D, et al. Immunohistochemical identification and localization of growth factors in feline postvaccinal lesions [abstract 150]. Vet Pathol 1996;33:607.
32. Hendrick MJ. Feline vaccine-associated sarcomas: current studies on pathogenesis. JAVMA 1998;213:1425-6.
33. Hendrick MJ. Feline vaccine-associated sarcomas. Cancer Invest 1999;17:273-7.
34. Couto SS, Griffey SM, Duarte PC, et al. Feline vaccine-associated fibrosarcoma: morphologic distinctions. Vet Pathol 2002;39:33-41.
35. Ellis JA, Jackson ML, Bartsch RC, et al. Use of immunohistochemistry and polymerase chain reaction for detection of oncornaviruses in formalin-fixed, paraffin-embedded fibrosarcomas from cats. JAVMA 1996;209:767-71.
36. Kidney BA, Ellis JA, Haines DM, et al. Comparison of endogenous feline leukemia virus RNA content in feline vaccine and nonvaccine site-associated sarcomas. Am J Vet Res 2001c;62:1990-4.
37. Kidney BA, Ellis JA, Haines DM, et al. Evaluation of formalin-fixed paraffin-embedded tissues obtained from vaccine site-associated sarcomas of cats for DNA of feline immunodeficiency virus. Am J Vet Res 2000;61:1037-41.
38. Kidney BA, Haines DM, Ellis JA, et al. Evaluation of formalin-fixed paraffin-embedded tissues from feline vaccine site-associated sarcomas for feline foamy virus DNA. Am J Vet Res 2002;63:60-3.
39. Kidney BA, Haines DM, Ellis JA, et al. Evaluation of formalin-fixed paraffin-embedded tissues from vaccine site-associated sarcomas of cats for papillomavirus DNA and antigen. Am J Vet Res 2001b;62:833-9.
40. Kidney BA, Haines DM, Ellis JA, et al. Evaluation of formalin-fixed paraffin-embedded tissues from vaccine site-associated sarcomas of cats for polyomavirus DNA and antigen. Am J Vet Res 2001a;62:828-32.
41. Nambiar PR, Haines DM, Ellis JA, et al. Mutational analysis of tumor suppressor gene p53 in feline vaccine site-associated sarcomas. Am J Vet Res 2000;61:1277-81.
42. Nambiar PR, Jackson ML, Ellis JA, et al. Immunohistochemical detection of tumor suppressor gene p53 protein in feline injection site-associated sarcomas. Vet Pathol 2001;38:236-8.
43. Hoots EA, McNeil EA, LaRue SM. Characterization of genetic alterations in feline vaccine-associated sarcoma using whole chromosome painting probes [abstract 83]. J Vet Intern Med 2001;15:292.
44. McNeil EA, Hoots EA, LaRue SM. Characterization of chromosomal aberrations in feline vaccine-associated sarcoma using comparative genomic hybridization [abstract 84]. J Vet Intern Med 2001;292.
45. McNeil EA. Vaccine-associated sarcomas in cats-a unique cancer model. Clin Orthop 2001:382:21-7.
46. Williams LE, Banerji N, Klausner JS, et al. Establishment of two vaccine-associated feline sarcoma cell lines and determination of in vitro chemosensitivity to doxorubicin and mitoxantrone. Am J Vet Res 2001;62:1354-7.
47. Banerji N, Li X, Klausner JS, et al. Evaluation of in vitro chemosensitivity of vaccine-associated feline sarcoma cell lines to vincristine and paclitaxel. Am J Vet Res 2002;63: 728-32.
48. Gagnon AC. Drug injection-associated fibrosarcoma in a cat. Feline Pract 2000;28:18-21.
49. McEntee MC, Samii VF. The utility of contrast enhanced computed tomography in feline vaccine associated sarcomas: 35 cases [abstract]. Vet Radiol Ultrasound 2000;41:575.
50. Kobayashi T, Hauck ML, Dodge R, et al. Preoperative radiotherapy for vaccine site sarcoma in 92 cats. Vet Radiol Ultrasound 2002;43:473-9.
51. Hershey AE, Sorenmo KU, Hendrick MJ, et al. Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986-1996). JAVMA 2000;216:58-61.
52. Bregazzi VS, LaRue SM, McNiel E, et al. Treatment with a combination of doxorubicin, surgery, and radiation versus surgery and radiation alone for cats with vaccine-associated sarcomas: 25 cases (1995-2000). JAVMA 2001;218:547-50.
53. Davidson EB, Gregory CR, Kass PH. Surgical excision of soft tissue fibrosarcomas in cats. Vet Surg 1997;26:265-9.
54. Lidbetter DA, Williams FA, Krahwinkel DJ, et al. Radical lateral body-wall resection for fibrosarcoma with reconstruction using polypropylene mesh and a caudal superficial epigastric axial pattern flap: a prospective clinical study of the technique and results in 6 cats. Vet Surg 2002;31:57-64.
55. Kuntz CA. Modified wide local excision for vaccine associated soft tissue sarcomas in cats [abstract 7]. Vet Surg 2000;29-481.
56. Rogers K, Walker MA, Barton CL, et al. Post-operative brachytherapy for vaccine-associated sarcoma in cats [abstract]. Vet Radiol Ultrasound 2000;41:577.
57. King GK, Harris DF, Hottinger H, et al. Prolonged remission and survival time in cats with injection-site sarcomas using pre-operative radiation and doxorubicin protocol: 61 cases (1998-2000) [abstract]. Vet Radiol Ultrasound 2001;42:585.
58. Cohen M, Wright JC, Brawner WR, et al. Use of surgery and electron beam irradiation, with or without chemotherapy, for treatment of vaccine-associated sarcomas in cats: 78 cases (1996-2000). JAVMA 2001;219:1582-9.
59. Cronin K, Page RL, Spodnick G, et al. Radiation therapy and surgery for fibrosarcoma in 33 Cats. Vet Radiol Ultrasound 1998;39:51-6.
60. Barber LG, Sorenmo KU, Cronin KL, et al. Combined doxorubicin and cyclophosphamide chemotherapy for nouresectable feline fibrosarcoma. J Am Anim Hosp Assoc 2000; 36:416-21.
61. Kleiter M, Leschnik M. Postoperative chemotherapie zur behandlung eines zweifach rezidivierten vakzine-assoziierten fibrosarkoms. Kleintierpraxis 1998;43:295-302.
62. Poider VJ, Thamm DH, Kurzman ID, et al. Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats. J Vet Intern Med 2002;16:726-31.
63. Harris C, Pierce K, King G, et al. Efficacy of acemannan in treatment of canine and feline spontaneous neoplasms. Mol Biother 1991;3:207-13.
64. Matteucci ML, Anyarambhatla G, Rosner G, et al, Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas. Clin Cancer Res 2000;6:3748-55.
65. Lappin MR, Andrews J, Simpson D, et al. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats. JAVMA 2002;220:38-42.
66. Krebs JW, Mondul AM, Rupprecht CE, et al. Rabies surveillance in the United States during 2000. JAVMA 2001;219:1687-99.
67. Krebs JW, Smith JS, Rupprecht CE, et al. Rabies surveillance in the United States during 1998. JAVMA 1999;215:1786-98.
68. Krebs JW, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 1999. JAVMA 2000;217:1799-811.
69. Moore DA, Sischo WM, Hunter A, et al. Animal bite epidemiology and surveillance for rabies postexposure prophylaxis. JAVMA 2000;217:190-4.